A Pilot Feasibility Study of TNFerade™ Biologic with Capecitabine and Radiation Therapy Followed by Surgical Resection for the Treatment of Rectal Cancer

Publisher： Karger

E-ISSN： 1423-0232|79|5-6|382-388

ISSN： 0030-2414

Source： Oncology, Vol.79, Iss.5-6, 2011-03, pp. : 382-388

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preoperative Treatment Combining Capecitabine with Radiation Therapy in Rectal Cancer: A GERCOR Phase II Study

By  

Oncology, Vol. 73, Iss. 3-4, 2008-04 ,pp. : 169-176

Karger

Access to resources Recommend Favorite

Safety and Feasibility of Carboplatin and Paclitaxel followed by Fluoropyrimidine Analogs and Radiation as Adjuvant Therapy for Gastric Cancer

By  

Case Reports in Oncology, Vol. 2, Iss. 3, 2009-11 ,pp. : 220-228

Karger

Access to resources Recommend Favorite

Chemoradiation therapy for rectal cancer in the distal rectum followed by organ‐sparing transanal endoscopic microsurgery (CARTS study)

By  

BRITISH JOURNAL OF SURGERY, Vol. 102, Iss. 7, 2015-06 ,pp. : 853-860

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Pilot Phase II Study of Capecitabine in Advanced or Recurrent Gastric Cancer

By  

Oncology, Vol. 64, Iss. 3, 2003-04 ,pp. : 232-236

Karger

Access to resources Recommend Favorite

Costs Associated with Capecitabine or 5-Fluorouracil Monotherapy after Surgical Resection in Patients with Colorectal Cancer

By  

Oncology, Vol. 77, Iss. 3-4, 2009-09 ,pp. : 244-253

Karger

Access to resources Recommend Favorite